特异性抗原-话题@MedSci - 梅斯（MedSci）

#特异性抗原#

26篇内容 | 1641人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1957853, encodeId=2c20195e85385, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=EU：欧洲泌尿外科协会：针对前列腺特异性抗原检测作为前列腺癌早期风险适应的一部分前列腺癌的检测策略 2021, objectType=article, longId=216166, objectId=45462161663d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45462161663d, replyNumber=0, likeNumber=76, createdTime=2021-10-28, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45462161663d, moduleTitle=EU：欧洲泌尿外科协会：针对前列腺特异性抗原检测作为前列腺癌早期风险适应的一部分前列腺癌的检测策略 2021, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45462161663d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957852, encodeId=3e56195e852b5, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Eur Urol Focus：残疾男性的前列腺特异性抗原检测, objectType=article, longId=215678, objectId=fdad2156e88f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdad2156e88f, replyNumber=0, likeNumber=88, createdTime=2021-09-24, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdad2156e88f, moduleTitle=Eur Urol Focus：残疾男性的前列腺特异性抗原检测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fdad2156e88f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957850, encodeId=0d4a195e85018, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究, objectType=article, longId=209870, objectId=fc2e2098e0ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2e2098e0ff, replyNumber=0, likeNumber=71, createdTime=2021-09-15, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2e2098e0ff, moduleTitle=BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fc2e2098e0ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957847, encodeId=5a9d195e8470b, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, objectType=article, longId=202311, objectId=bf812023119e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf812023119e, replyNumber=0, likeNumber=86, createdTime=2021-02-26, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf812023119e, moduleTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bf812023119e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957851, encodeId=946b195e8515b, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Cancer：前列腺癌活检格林森评分9到10患者的前列腺特异性抗原水平和前列腺癌特异性死亡风险 , objectType=article, longId=213155, objectId=80b4213155e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80b4213155e3, replyNumber=0, likeNumber=80, createdTime=2022-05-05, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80b4213155e3, moduleTitle=Cancer：前列腺癌活检格林森评分9到10患者的前列腺特异性抗原水平和前列腺癌特异性死亡风险 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=80b4213155e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957848, encodeId=4342195e8487f, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Sci Rep：使用前列腺特异性抗原密度预测临床显著性前列腺癌, objectType=article, longId=203897, objectId=76b020389e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76b020389e10, replyNumber=0, likeNumber=82, createdTime=2021-05-13, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76b020389e10, moduleTitle=Sci Rep：使用前列腺特异性抗原密度预测临床显著性前列腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=76b020389e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957849, encodeId=0ce2195e849fe, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Cancers (Basel)：局部前列腺癌患者经尿道前列腺切除术后的前列腺特异性抗原变化的预测作用 , objectType=article, longId=205679, objectId=086d2056e9ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086d2056e9ce, replyNumber=0, likeNumber=126, createdTime=2021-08-16, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086d2056e9ce, moduleTitle=Cancers (Basel)：局部前列腺癌患者经尿道前列腺切除术后的前列腺特异性抗原变化的预测作用 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=086d2056e9ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957844, encodeId=0fd6195e8445f, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , objectType=article, longId=192841, objectId=60cc192841a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cc192841a6, replyNumber=0, likeNumber=95, createdTime=2020-05-22, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cc192841a6, moduleTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=60cc192841a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957845, encodeId=538e195e84545, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , objectType=article, longId=193105, objectId=db55193105ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db55193105ab, replyNumber=0, likeNumber=70, createdTime=2020-10-24, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db55193105ab, moduleTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=db55193105ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957846, encodeId=ed0c195e84663, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况 , objectType=article, longId=193848, objectId=df811938489b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df811938489b, replyNumber=0, likeNumber=61, createdTime=2021-04-06, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df811938489b, moduleTitle=Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=df811938489b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957843, encodeId=17b5195e843a7, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究, objectType=article, longId=178499, objectId=25511e849963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25511e849963, replyNumber=0, likeNumber=75, createdTime=2020-04-22, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25511e849963, moduleTitle=Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25511e849963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957842, encodeId=b00e195e8426b, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？, objectType=article, longId=175353, objectId=37da1e53535d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37da1e53535d, replyNumber=0, likeNumber=66, createdTime=2019-09-15, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37da1e53535d, moduleTitle=JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=37da1e53535d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957839, encodeId=f7ed195e83929, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Urology：核磁共振成像确定的前列腺特异性抗原密度能够显著的改善前列腺癌活检的风险预测, objectType=article, longId=157393, objectId=2a8f15e393a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a8f15e393a4, replyNumber=0, likeNumber=73, createdTime=2019-12-04, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a8f15e393a4, moduleTitle=Urology：核磁共振成像确定的前列腺特异性抗原密度能够显著的改善前列腺癌活检的风险预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2a8f15e393a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957841, encodeId=1fed195e84140, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究, objectType=article, longId=159568, objectId=173d15956832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173d15956832, replyNumber=0, likeNumber=69, createdTime=2019-12-10, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173d15956832, moduleTitle=ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=173d15956832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957837, encodeId=56df195e8372e, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=2018 临床实践指南：前列腺特异性抗原（PSA）检测进行前列腺癌筛查, objectType=article, longId=148761, objectId=7d7e148e6169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d7e148e6169, replyNumber=0, likeNumber=80, createdTime=2018-09-28, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d7e148e6169, moduleTitle=2018 临床实践指南：前列腺特异性抗原（PSA）检测进行前列腺癌筛查, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7d7e148e6169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957840, encodeId=db83195e840b0, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能, objectType=article, longId=157433, objectId=249115e43356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=249115e43356, replyNumber=0, likeNumber=80, createdTime=2019-08-05, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=249115e43356, moduleTitle=CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=249115e43356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957838, encodeId=e08e195e838e9, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=ARCH PATHOL LAB MED：前列腺癌抗原3和前列腺特异性抗原的组合可提高患有前列腺癌风险男性的诊断准确性, objectType=article, longId=154768, objectId=ff52154e682d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff52154e682d, replyNumber=0, likeNumber=69, createdTime=2019-05-21, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff52154e682d, moduleTitle=ARCH PATHOL LAB MED：前列腺癌抗原3和前列腺特异性抗原的组合可提高患有前列腺癌风险男性的诊断准确性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ff52154e682d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957835, encodeId=a552195e83553, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Cancer Causes Control：糖尿病、前列腺特异性抗原筛选与前列腺癌之间的关系研究, objectType=article, longId=146768, objectId=21df146e68bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21df146e68bb, replyNumber=0, likeNumber=83, createdTime=2019-02-22, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21df146e68bb, moduleTitle=Cancer Causes Control：糖尿病、前列腺特异性抗原筛选与前列腺癌之间的关系研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=21df146e68bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957833, encodeId=73a2195e8331a, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=Brit J Cancer：在前瞻性前列腺癌筛选研究中，具有遗传易感性男性前列腺特异性抗原速度分析, objectType=article, longId=126714, objectId=28b4126e149b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28b4126e149b, replyNumber=0, likeNumber=71, createdTime=2018-12-27, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28b4126e149b, moduleTitle=Brit J Cancer：在前瞻性前列腺癌筛选研究中，具有遗传易感性男性前列腺特异性抗原速度分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28b4126e149b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1957836, encodeId=ac1b195e8367e, content=<a href='/topic/show?id=41cb6e95555' target=_blank style='color:#2F92EE;'>#特异性抗原#</a>, objectTitle=BMJ：前列腺特异性抗原筛查的效果及安全性研究, objectType=article, longId=148567, objectId=2fee14856e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fee14856e6d, replyNumber=0, likeNumber=65, createdTime=2018-12-10, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fee14856e6d, moduleTitle=BMJ：前列腺特异性抗原筛查的效果及安全性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2fee14856e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性抗原

2020-05-29

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

EU：欧洲泌尿外科协会：针对前列腺特异性抗原检测作为前列腺癌早期风险适应的一部分前列腺癌的检测策略 2021

2021-10-28

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Eur Urol Focus：残疾男性的前列腺特异性抗原检测

2021-09-24

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

BJU Int：游离/总前列腺特异性抗原（PSA）检测与前列腺癌死亡率之间的关联研究

2021-09-15

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究

2021-02-26

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Cancer：前列腺癌活检格林森评分9到10患者的前列腺特异性抗原水平和前列腺癌特异性死亡风险

2022-05-05

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Sci Rep：使用前列腺特异性抗原密度预测临床显著性前列腺癌

2021-05-13

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Cancers (Basel)：局部前列腺癌患者经尿道前列腺切除术后的前列腺特异性抗原变化的预测作用

2021-08-16

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应

2020-05-22

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查

2020-10-24

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Cancer：医疗补助扩大后前列腺癌诊断时前列腺特异性抗原水平变化情况

2021-04-06

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究

2020-04-22

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？

2019-09-15

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Urology：核磁共振成像确定的前列腺特异性抗原密度能够显著的改善前列腺癌活检的风险预测

2019-12-04

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究

2019-12-10

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

2018 临床实践指南：前列腺特异性抗原（PSA）检测进行前列腺癌筛查

2018-09-28

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能

2019-08-05

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

ARCH PATHOL LAB MED：前列腺癌抗原3和前列腺特异性抗原的组合可提高患有前列腺癌风险男性的诊断准确性

2019-05-21

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Cancer Causes Control：糖尿病、前列腺特异性抗原筛选与前列腺癌之间的关系研究

2019-02-22

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

Brit J Cancer：在前瞻性前列腺癌筛选研究中，具有遗传易感性男性前列腺特异性抗原速度分析

2018-12-27

ms4657536712156177 (审核中...)

前往app查看评论内容

#特异性抗原#

BMJ：前列腺特异性抗原筛查的效果及安全性研究

2018-12-10

科室
- - 订阅+
  - 更多科室
工具
服务